share_log

信達生物:委任董事及變更董事委員會組成

INNOVENT BIO: APPOINTMENT OF DIRECTORS AND CHANGE IN COMPOSITION OF BOARD COMMITTEES

Hong Kong Stock Exchange ·  May 3 22:22
Summary by Futu AI
信達生物製藥有限公司(「信達生物」)於2024年5月3日宣布,陳樹云先生和張倩女士分別被委任為公司的獨立非執行董事及執行董事。陳樹云先生將同時擔任董事會薪酬委員會、戰略委員會及提名委員會的成員,而張倩女士則加入戰略委員會。陳先生曾於資本集團工作超過18年,並於2024年從該集團退休。張女士自2012年加入信達生物,現任集團首席人才官及多家全資附屬公司的總經理或監事。董事會對兩位新任董事的加入表示熱烈歡迎。
信達生物製藥有限公司(「信達生物」)於2024年5月3日宣布,陳樹云先生和張倩女士分別被委任為公司的獨立非執行董事及執行董事。陳樹云先生將同時擔任董事會薪酬委員會、戰略委員會及提名委員會的成員,而張倩女士則加入戰略委員會。陳先生曾於資本集團工作超過18年,並於2024年從該集團退休。張女士自2012年加入信達生物,現任集團首席人才官及多家全資附屬公司的總經理或監事。董事會對兩位新任董事的加入表示熱烈歡迎。
SINDA BIOPHARMACEUTICAL CO., LTD. (“SINDA BIOMICS”) ANNOUNCED ON 3 MAY 2024 THAT MR. CHEN SHUYUN AND MS. CHANG QIAN HAVE BEEN APPOINTED AS INDEPENDENT NON-EXECUTIVE DIRECTORS AND EXECUTIVE DIRECTORS OF THE COMPANY, RESPECTIVELY. Mr. CHAN Shu-yun will simultaneously serve as a member of the Board's Remuneration Committee, Strategic Committee and Nomination Committee, while Ms. Zhang Qian will join the Strategy Committee. Mr. Chan has worked for Capital Group for more than 18 years and will retire from the group in 2024. Ms. Zhang has joined Sinda Bio since 2012, serving as Group Chief Talent Officer and Managing Director or Supervisor of several wholly-owned subsidiaries. The Board warmly welcomes the addition of the two new directors.
SINDA BIOPHARMACEUTICAL CO., LTD. (“SINDA BIOMICS”) ANNOUNCED ON 3 MAY 2024 THAT MR. CHEN SHUYUN AND MS. CHANG QIAN HAVE BEEN APPOINTED AS INDEPENDENT NON-EXECUTIVE DIRECTORS AND EXECUTIVE DIRECTORS OF THE COMPANY, RESPECTIVELY. Mr. CHAN Shu-yun will simultaneously serve as a member of the Board's Remuneration Committee, Strategic Committee and Nomination Committee, while Ms. Zhang Qian will join the Strategy Committee. Mr. Chan has worked for Capital Group for more than 18 years and will retire from the group in 2024. Ms. Zhang has joined Sinda Bio since 2012, serving as Group Chief Talent Officer and Managing Director or Supervisor of several wholly-owned subsidiaries. The Board warmly welcomes the addition of the two new directors.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.